December 2022

Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Junshi Biosciences and Coherus are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC

>

3.3 degrees Celsius recorded in Taiwan’s Nantou on Sunday

Taiwan’s Central Weather Bureau (CWB) recorded a temperature as low as 3.3 degrees Celsius in Zhongliao Township, Nantou County, early Sunday morning, the lowest in low-lying areas on Taiwan proper, amid an ongoing cold spell.Also being hit by temperat…

>

Lai vows to help DPP return to roots if elected chairperson

Vice President Lai Ching-te (???) on Saturday said he would re-establish the Democratic Progressive Party’s (DPP) reputation for clean and diligent governance if elected party chairman.Lai, currently on a nationwide campaign tour for the DPP chairperso…

>

Taiwan’s cold spell forecast to weaken next week

A cold spell that is currently blanketing Taiwan, bringing freezing weather across the country, is expected to continue over the weekend before weakening on Monday (Dec. 26), according to the Central Weather Bureau (CWB).The CWB said daytime temperatur…

>